BBy utilizes a proprietary condensing technology to remove unbound water from breast milk, creating a shelf-stable powder that retains its nutritional and immunological properties. This method eliminates the need for freezing, reducing energy costs and streamlining the administration process in neonatal intensive care units (NICUs).
Funding
$3.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AGSKFounders
Product
Problem
Neonatal intensive care units (NICUs) face challenges in managing and storing breast milk, which traditionally requires freezing. This process is energy-intensive, can lead to logistical complexities, and may delay milk administration to infants.
Solution
BBy offers a technology to condense and shelf-stabilize breast milk, preserving its nutritional and immunological properties without freezing. The condensing process removes unbound water, resulting in a product that can be stored at room temperature and easily reconstituted. This approach simplifies breast milk management in hospitals, reduces energy consumption, and enables quicker administration, potentially improving patient outcomes and optimizing nursing time. The batched and sorted milk aims to reduce errors and streamline workflows within the NICU.
Target Audience
The primary target audience includes hospitals and neonatal intensive care units (NICUs) seeking to improve breast milk management, reduce energy costs, and enhance patient care.
Features
- Proprietary condensing technology to remove unbound water from breast milk
- Shelf-stable storage at room temperature, eliminating the need for freezers
- Simplified reconstitution process with a 1:1 ratio to uncondensed milk
- Batched and sorted milk for easy administration and reduced errors
- Pasteurization standards enable denaturing and removal of COVID-19 from milk